Skip to main content
Asymptomatic carotid artery stenosis screening

Asymptomatic carotid artery stenosis screening

Best Practice Guidance

How up to date is this information?

Published January 2023 | Last reviewed September 2024


Using this guidance

The guidance set out here was reviewed extensively in the Autumn of 2024. There are no plans for any further reviews.

Medicine is constantly evolving and over time it is inevitable that the evidence base will change. Please use your own judgement and/or other sources of clinical guidance alongside the information set out here.

Please note this guidance is a recommendation and it should be used in the context of the overall care pathway and when all alternative interventions that may be available locally have been undertaken.

Summary

Extracranial internal carotid stenosis, narrowing of the lumen of the internal carotid arteries, is most commonly attributed to atherosclerotic plaque formation and may present symptomatically as a Transient Ischaemic Attack (TIA) or ischaemic stroke. Carotid artery stenosis is thought to be the cause of approximately 8% of all ischaemic strokes. However, in some cases asymptomatic carotid artery stenosis may be identified as either an incidental finding on imaging or in individuals with known vascular disease, such as coronary atherosclerosis, peripheral arterial disease, abdominal aortic aneurysm or contralateral carotid stenosis. Asymptomatic carotid artery stenosis is defined as luminal narrowing in the absence of a history of TIA, ischaemic stroke, or other neurological signs
or symptoms attributable to carotid artery disease.

Investigation of carotid artery stenosis may involve use of carotid duplex ultrasound, CT angiography and MR angiography. However, the increased risks of ionising radiation and adverse reactions to intravenous contrast mean CT and MR-based imaging would be more suitable for second line imaging to define the anatomy in more detail, rather than as a screening method. Carotid duplex ultrasound is a non-invasive method used to measure blood flow through the carotid arteries. It enables quantification of the degree of luminal narrowing with atherosclerotic disease, based on the North American Symptomatic Carotid Endarterectomy Trial (NASCET) measurements. A meta-analysis identified that duplex ultrasound in the detection of greater than 50% angiographic stenosis of the internal carotid arteries has a sensitivity and specificity of 98% and 88% respectively compared to angiography.

Recommendation

This guidance applies to those 18 years and over.

  • Screening for carotid artery stenosis should NOT be performed in asymptomatic individuals
  • There is no indication for asymptomatic screening even in patients with known peripheral vascular disease
  • Other than to risk stratify patients for coronary intervention, there is no indication for asymptomatic screening of the carotid arteries in patients undergoing other forms of cardiac surgery
  • There is no routine indication for follow up for asymptomatic patients with carotid artery stenosis.

Please note that this guidance is intended as a standard threshold for access. However, if you/ your patient falls outside of these criteria, the option to apply for an Individual Funding Request is still available to you.

Additionally, there is no evidence that patients diagnosed with peripheral vascular disease benefit from undergoing carotid artery stenosis screening for this indication only. There is no clear evidence for being able to risk stratify an asymptomatic patient population for carotid artery stenosis screening.

Rationale for recommendation

The Royal College of Physicians’ 5th National Clinical Guideline for Stroke (2016)
recommended against screening for asymptomatic carotid artery disease and
recommended that surgery or angioplasty/stenting for asymptomatic coronary artery
disease should not be routinely performed unless as part of a clinical trial.
The United States Preventative Services Task Force in 2014 recommended against
screening for asymptomatic carotid artery stenosis amongst the general population. This
guidance was reaffirmed in 2021 following a comprehensive review which identified that,
within the general population, the risks of harm from screening for asymptomatic carotid
artery stenosis outweigh the benefits.
In a general population, duplex ultrasound screening may yield many false-positive
results. This is also supported by The European Society for Vascular Surgery guidelines.
These guidelines note that an unselected screening of patients aged >80 years for severe
stenosis (>70%) would be <2%, which is not clinically effective. This yield would be even
less in a younger screened population.

Patient information

The carotid arteries (major blood vessels in the neck) can become narrowed by deposition of fatty substances in the arterial wall (atherosclerotic plaque build-up). Narrowing can cause symptoms, such as a Transient Ischaemic Attack (TIA) or ischaemic stroke (where blood supply to the brain is reduced). However, only 8% of all ischaemic strokes are caused by narrowed carotid arteries. Often the narrowing (stenosis) causes no symptoms.

The EBI programme looked at the evidence for and against imaging (screening) the carotid arteries of patients who had no symptoms. Based on the evidence, the EBI programme recommends that patients without symptoms should not be referred for imaging. If a patient is found to have narrowed arteries, they do not require follow up if they continue to have no symptoms. However, if a patient does have symptoms or evidence of an ischaemic event in the brain, they should be referred for a duplex ultrasound of the arteries as the first-line investigation.

We recommend using the BRAN principles (Benfits, Risks, Alternatives and do Nothing) when speaking with patients about this.

Further information on patient involvement in EBI can be found on the EBI for patients section.

 

 

Coding

Admitted Patient Care
WHEN ( Any_Spell_Procedure LIKE '%U111%'
OR 
( ( Any_Spell_Procedure LIKE '%U117%' 
OR Any_Spell_Procedure LIKE '%U21[126]%' 
OR Any_Spell_Procedure LIKE '%U355%')
AND ( Any_Spell_Procedure LIKE '%Z361%'
OR Any_Spell_Procedure LIKE '%Z95[567]%') )
)
AND (NOT ( Any_Spell_Diagnosis LIKE '%I63[01289]%' 
OR Any_Spell_Diagnosis LIKE '%G45[123489]%')
OR Any_Spell_Diagnosis IS NULL )
-- Only Elective Activity
AND APCS.Admission_Method NOT LIKE '2%'
-- Age between 18 and 120
AND isnull(APCS.Age_At_Start_of_Spell_SUS,APCS.Der_Age_at_CDS_Activity_Date) between 18 AND 120
THEN '3E_Carotid_Stenosis_Screening'
Exclusions
WHERE 1=1
-- Cancer Diagnosis Exclusion
AND (Any_Spell_Diagnosis not like '%C[0-9][0-9]%' 
AND Any_Spell_Diagnosis not like '%D0%' 
AND Any_Spell_Diagnosis not like '%D3[789]%' 
AND Any_Spell_Diagnosis not like '%D4[012345678]%' 
OR Any_Spell_Diagnosis IS NULL)

-- Private Appointment Exclusion 
AND apcs.Administrative_Category<>'02'

Outpatient
WHEN ( Any_Appointment_Procedure LIKE '%U111%'
OR 
( ( Any_Appointment_Procedure LIKE '%U117%' 
OR Any_Appointment_Procedure LIKE '%U21[126]%' 
OR Any_Appointment_Procedure LIKE '%U355%')
AND ( Any_Appointment_Procedure LIKE '%Z361%'
OR Any_Appointment_Procedure LIKE '%Z95[567]%') )
) 
AND (NOT ( Any_Appointment_Diagnosis LIKE '%I63[01289]%' 
OR Any_Appointment_Diagnosis LIKE '%G45[123489]%')
OR Any_Appointment_Diagnosis IS NULL )
-- Age Between 19 and 120
AND isnull(OPA.Age_at_Start_of_Episode_SUS,OPA.Der_Age_at_CDS_Activity_Date) between 18 AND 120
THEN '3E_Carotid_Stenosis_Screening'
Exclusions
WHERE 1=1
-- Patient Has Attended Appointment
AND Attendance_Status IN (5,6)
-- Cancer Diagnosis Exclusion Codes
AND (( Any_Appointment_Diagnosis not like '%C[0-9][0-9]%' 
AND Any_Appointment_Diagnosis not like '%D0%' 
AND Any_Appointment_Diagnosis not like '%D3[789]%' 
AND Any_Appointment_Diagnosis not like '%D4[012345678]%') 
OR Any_Appointment_Diagnosis IS NULL)
-- Private Appointment Exclusion
AND opa.Administrative_Category<>'02'

References

  1.   Flaherty, M. L., et al. 2013. Carotid artery stenosis as a cause of stroke. Neuroepidemiology 40(1): 36-41.
  2. Force, U. P. S. T. 2021. Screening for Asymptomatic Carotid Artery Stenosis: US Preventive Services Task Force Recommendation Statement. JAMA 325(5):476-481.
  3. Mortimer, R., et al. 2018. Carotid artery stenosis screening: where are we now? The British Journal of Radiology. 91(1090): 20170380-20170380.
  4. Barnett, H. J. M., et al. 1991. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325(7): 445-453.
  5. Jahromi, A. S., et al. 2005. Sensitivity and specificity of color duplex ultrasound measurement in the estimation of internal carotid artery stenosis: A systematic review and meta-analysis. Journal of Vascular Surgery 41(6): 962-972.
  6. Royal College of Physicians. National clinical guideline for stroke 5th edition. London. 2016 Royal College of Physicians
  7. Naylor A.R, Ricco J-b, de Borst G.J et al Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg (2018) 55, 3e81
  8. Thapar A, Munster A, Shalhoub J, Davies A, Testing for asymptomatic carotid disease in patients with arterial disease elsewhere. Reviews in Vascular Medicine 1(4):81-84
  9. NICE. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management [NG128]. 2019